Search results for "VOLUME"

showing 2 items of 1932 documents

Analysis of the Potential of an Increase in Yeast Output Resulting from the Application of Additional Process Wastewater in the Evaporator Station

2019

This paper reports the results of an analysis of process wastewater streams in the context of an increase in yeast production. This research is based on the analysis of data from the biggest yeast factory in Europe. The research presented in this paper involves the analysis of the influence of direction of additional wastewater into the evaporator station on yeast production. In the process wastewater, nitrogen is mainly present in organic forms. The analysis reported in this paper involves the concentration of total nitrogen in wastewater streams, as it is the main parameter applied to determine the amount of wastewater that can be applied in agricultural fields. Directing additional waste…

yeast wastewater0211 other engineering and technologieschemistry.chemical_elementContext (language use)environmental engineering; production increase; yeast wastewater; sustainability02 engineering and technology010501 environmental sciencesengineering.material01 natural scienceslcsh:Technologylcsh:ChemistryProduction (economics)General Materials ScienceInstrumentationlcsh:QH301-705.5Evaporator0105 earth and related environmental sciencesFluid Flow and Transfer Processesproduction increase021110 strategic defence & security studiesenvironmental engineeringlcsh:TProcess Chemistry and TechnologyGeneral EngineeringEnvironmental engineeringsustainabilityNitrogenlcsh:QC1-999Computer Science ApplicationsVolume (thermodynamics)Wastewaterchemistrylcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040engineeringEnvironmental scienceFertilizerlcsh:Engineering (General). Civil engineering (General)Organic fertilizerlcsh:PhysicsApplied Sciences
researchProduct

Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 mon…

2014

Summary Background In patients with COPD, exacerbations are associated with poor quality of life and may shorten survival. Prevention of exacerbations is, therefore, a key objective in COPD management. Indacaterol, a once-daily ultra-long-acting β 2 -agonist, has been shown to reduce exacerbations in various studies. This pooled analysis evaluated the effect of indacaterol on exacerbations versus placebo. Methods Six-month data were pooled from three randomized, double-blind, and placebo-controlled studies: indacaterol 300 μg versus placebo (1 year); indacaterol 150 μg and 300 μg versus placebo (6 months); and indacaterol 150 μg versus placebo (6 months). All treatments were administered on…

β2-agonistPulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationKaplan-Meier EstimateQuinolonesPlaceboDrug Administration SchedulePooled analysisExacerbationsPulmonary Disease Chronic ObstructiveFEV1/FVC ratioDouble-Blind MethodForced Expiratory VolumeInternal medicineHumansCOPDMedicineAdrenergic beta-2 Receptor AgonistsRandomized Controlled Trials as TopicIndacaterolCOPDDose-Response Relationship Drugbusiness.industryMinimal clinically important differenceHazard ratiomedicine.diseaseConfidence intervalBronchodilator AgentsClinical Trials Phase III as TopicAnesthesiaIndansIndacaterolbusinessBronchodilatormedicine.drugRespiratory Medicine
researchProduct